These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 27225804)

  • 1. Clinical and prognostic utility of cardiovascular magnetic resonance imaging in myeloma patients with suspected cardiac amyloidosis.
    Bhatti S; Watts E; Syed F; Vallurupalli S; Pandey T; Jambekar K; Mazur W; Hakeem A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):970-7. PubMed ID: 27225804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis.
    Boynton SJ; Geske JB; Dispenzieri A; Syed IS; Hanson TJ; Grogan M; Araoz PA
    JACC Cardiovasc Imaging; 2016 Jun; 9(6):680-6. PubMed ID: 27209101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
    Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis.
    Austin BA; Tang WH; Rodriguez ER; Tan C; Flamm SD; Taylor DO; Starling RC; Desai MY
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1369-77. PubMed ID: 20083070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Prognostic Value of Query Amyloid Late Enhancement Score in Light-Chain Cardiac Amyloidosis.
    Wan K; Sun J; Han Y; Liu H; Yang D; Li W; Wang J; Cheng W; Zhang Q; Zeng Z; Chen Y
    Circ J; 2018 Feb; 82(3):739-746. PubMed ID: 29093431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of late gadolinium enhancement in the risk stratification of heart transplant patients.
    Pedrotti P; Vittori C; Facchetti R; Pedretti S; Dellegrottaglie S; Milazzo A; Frigerio M; Cipriani M; Giannattasio C; Roghi A; Rimoldi O
    Eur Heart J Cardiovasc Imaging; 2017 Feb; 18(2):130-137. PubMed ID: 27625368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I; Bezerra H; Carrick D; Tzemos N
    JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis.
    Raina S; Lensing SY; Nairooz RS; Pothineni NV; Hakeem A; Bhatti S; Pandey T
    JACC Cardiovasc Imaging; 2016 Nov; 9(11):1267-1277. PubMed ID: 27568115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of myocardial contraction fraction and long-axis strain to predict late gadolinium enhancement in multiple myeloma patients with secondary cardiac amyloidosis.
    Hu M; Song Y; Yang C; Wang J; Zhu W; Kan A; Yang P; Dai J; Yu H; Gong L
    Sci Rep; 2024 Jul; 14(1):16832. PubMed ID: 39039146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis.
    Wan K; Sun J; Han Y; Luo Y; Liu H; Yang D; Cheng W; Zhang Q; Zeng Z; Chen Y
    Heart Vessels; 2018 Feb; 33(2):170-179. PubMed ID: 28840397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
    Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the prognostic relevance of myocardial ischaemia and scar by cardiac magnetic resonance in patients with and without diabetes mellitus.
    Giusca S; Kelle S; Nagel E; Buss SJ; Voss A; Puntmann V; Fleck E; Katus HA; Korosoglou G
    Eur Heart J Cardiovasc Imaging; 2016 Jul; 17(7):812-20. PubMed ID: 26358695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis.
    Ochs MM; Fritz T; Arenja N; Riffel J; Andre F; Mereles D; Siepen FAD; Hegenbart U; Schönland S; Katus HA; Friedrich MGW; Buss SJ
    J Cardiovasc Magn Reson; 2017 Nov; 19(1):87. PubMed ID: 29121956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis.
    Maceira AM; Prasad SK; Hawkins PN; Roughton M; Pennell DJ
    J Cardiovasc Magn Reson; 2008 Nov; 10(1):54. PubMed ID: 19032744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late gadolinium enhanced cardiac MR derived radiomics approach for predicting all-cause mortality in cardiac amyloidosis: a multicenter study.
    Zhou XY; Tang CX; Guo YK; Chen WC; Guo JZ; Ren GS; Li X; Li JH; Lu GM; Huang XH; Wang YN; Zhang LJ; Yang GF
    Eur Radiol; 2024 Jan; 34(1):402-410. PubMed ID: 37552255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study.
    Chatzantonis G; Bietenbeck M; Elsanhoury A; Tschöpe C; Pieske B; Tauscher G; Vietheer J; Shomanova Z; Mahrholdt H; Rolf A; Kelle S; Yilmaz A
    Clin Res Cardiol; 2021 Apr; 110(4):555-568. PubMed ID: 33170349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging.
    Mekinian A; Lions C; Leleu X; Duhamel A; Lamblin N; Coiteux V; De Groote P; Hatron PY; Facon T; Beregi JP; Hachulla E; Launay D;
    Am J Med; 2010 Sep; 123(9):864-8. PubMed ID: 20800158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Transit Time Derived from First-Pass Perfusion Cardiac MR Imaging: A Potential New Marker for Cardiac Involvement and Prognosis in Light-Chain Amyloidosis.
    Bi K; Wan K; Xu Y; Wang J; Li W; Guo J; Xu Z; Li Y; Deng Q; Cheng W; Sun J; Chen Y
    J Magn Reson Imaging; 2024 Sep; 60(3):999-1010. PubMed ID: 37972587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis.
    Cavalcante JL; Rijal S; Abdelkarim I; Althouse AD; Sharbaugh MS; Fridman Y; Soman P; Forman DE; Schindler JT; Gleason TG; Lee JS; Schelbert EB
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):98. PubMed ID: 29212513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.